Cure My Disease

Don't miss your cure!

 Log in / Sign up

Experimental drug TJ037130 takes aim at advanced solid tumors

NCT ID NCT07715747

Not yet recruiting Disease control Sponsor: TJ Biopharma Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This phase 1 trial tests an experimental drug called TJ037130 in adults with advanced solid tumors, including ovarian, gastric, and endometrial cancers that have spread. The main goal is to check the drug's safety and find the best dose for future studies. Participants receive TJ037130 by infusion once every three weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
an experimental drug called TJ037130
What this could lead to
If it works, this could point toward a new treatment option for people with advanced solid tumors who have run out of standard therapies.
What could go wrong
This is an early phase 1 trial with a small number of participants, so the drug may prove unsafe or ineffective. Side effects are unknown and could be serious.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

endometrial carcinoma endometrium neoplasm gastric cancer gastric neoplasm neoplasm ovarian cancer ovarian carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

METASTATIC ENDOMETRIAL CARCINOMA METASTATIC GASTRIC CANCER METASTATIC OVARY CANCER SOLID TUMOR

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Shanghai GoBroad Cancer Hospital

    Shanghai, Shanghai Municipality, China

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.